375 related articles for article (PubMed ID: 37154858)
1.
Samakkarnthai P; Saul D; Zhang L; Aversa Z; Doolittle ML; Sfeir JG; Kaur J; Atkinson EJ; Edwards JR; Russell GG; Pignolo RJ; Kirkland JL; Tchkonia T; Niedernhofer LJ; Monroe DG; Lebrasseur NK; Farr JN; Robbins PD; Khosla S
Aging (Albany NY); 2023 May; 15(9):3331-3355. PubMed ID: 37154858
[TBL] [Abstract][Full Text] [Related]
2.
Samakkarnthai P; Saul D; Zhang L; Aversa Z; Doolittle ML; Sfeir JG; Kaur J; Atkinson EJ; Edwards JR; Russell RGG; Pignolo RJ; Kirkland JL; Tchkonia T; Niedernhofer LJ; Monroe DG; LeBrasseur NK; Farr JN; Robbins PD; Khosla S
bioRxiv; 2023 Feb; ():. PubMed ID: 36865244
[TBL] [Abstract][Full Text] [Related]
3. Senotherapeutic-like effect of Silybum marianum flower extract revealed on human skin cells.
Woo J; Shin S; Cho E; Ryu D; Garandeau D; Chajra H; Fréchet M; Park D; Jung E
PLoS One; 2021; 16(12):e0260545. PubMed ID: 34914725
[TBL] [Abstract][Full Text] [Related]
4. A guide to senolytic intervention in neurodegenerative disease.
Lee S; Wang EY; Steinberg AB; Walton CC; Chinta SJ; Andersen JK
Mech Ageing Dev; 2021 Dec; 200():111585. PubMed ID: 34627838
[TBL] [Abstract][Full Text] [Related]
5. Cellular senescence in bone.
Farr JN; Khosla S
Bone; 2019 Apr; 121():121-133. PubMed ID: 30659978
[TBL] [Abstract][Full Text] [Related]
6. Cellular Senescence in Diabetes Mellitus: Distinct Senotherapeutic Strategies for Adipose Tissue and Pancreatic β Cells.
Murakami T; Inagaki N; Kondoh H
Front Endocrinol (Lausanne); 2022; 13():869414. PubMed ID: 35432205
[TBL] [Abstract][Full Text] [Related]
7. Targeting cellular senescence with senotherapeutics: senolytics and senomorphics.
Zhang L; Pitcher LE; Prahalad V; Niedernhofer LJ; Robbins PD
FEBS J; 2023 Mar; 290(5):1362-1383. PubMed ID: 35015337
[TBL] [Abstract][Full Text] [Related]
8. Cellular Senescence Contributes to Large Elastic Artery Stiffening and Endothelial Dysfunction With Aging: Amelioration With Senolytic Treatment.
Clayton ZS; Rossman MJ; Mahoney SA; Venkatasubramanian R; Maurer GS; Hutton DA; VanDongen NS; Greenberg NT; Longtine AG; Ludwig KR; Brunt VE; LaRocca TJ; Campisi J; Melov S; Seals DR
Hypertension; 2023 Oct; 80(10):2072-2087. PubMed ID: 37593877
[TBL] [Abstract][Full Text] [Related]
9. Mitochondria-targeted senotherapeutic interventions.
Atayik MC; Çakatay U
Biogerontology; 2022 Aug; 23(4):401-423. PubMed ID: 35781579
[TBL] [Abstract][Full Text] [Related]
10. Synergistic roles of CBX4 chromo and SIM domains in regulating senescence of primary human osteoarthritic chondrocytes.
Chen YH; Zhang X; Attarian D; Kraus VB
Arthritis Res Ther; 2023 Oct; 25(1):197. PubMed ID: 37828576
[TBL] [Abstract][Full Text] [Related]
11. The power of proteomics to monitor senescence-associated secretory phenotypes and beyond: toward clinical applications.
Basisty N; Kale A; Patel S; Campisi J; Schilling B
Expert Rev Proteomics; 2020 Apr; 17(4):297-308. PubMed ID: 32425074
[TBL] [Abstract][Full Text] [Related]
12. The implication of ROCK 2 as a potential senotherapeutic target via the suppression of the harmful effects of the SASP: Do senescent cancer cells really engulf the other cells?
Şimay Demir YD; Özdemir A; Sucularlı C; Benhür E; Ark M
Cell Signal; 2021 Aug; 84():110007. PubMed ID: 33845155
[TBL] [Abstract][Full Text] [Related]
13. Modulation of fracture healing by senescence-associated secretory phenotype (SASP): a narrative review of the current literature.
Zhao S; Qiao Z; Pfeifer R; Pape HC; Mao K; Tang H; Meng B; Chen S; Liu H
Eur J Med Res; 2024 Jan; 29(1):38. PubMed ID: 38195489
[TBL] [Abstract][Full Text] [Related]
14. Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease.
Hickson LJ; Langhi Prata LGP; Bobart SA; Evans TK; Giorgadze N; Hashmi SK; Herrmann SM; Jensen MD; Jia Q; Jordan KL; Kellogg TA; Khosla S; Koerber DM; Lagnado AB; Lawson DK; LeBrasseur NK; Lerman LO; McDonald KM; McKenzie TJ; Passos JF; Pignolo RJ; Pirtskhalava T; Saadiq IM; Schaefer KK; Textor SC; Victorelli SG; Volkman TL; Xue A; Wentworth MA; Wissler Gerdes EO; Zhu Y; Tchkonia T; Kirkland JL
EBioMedicine; 2019 Sep; 47():446-456. PubMed ID: 31542391
[TBL] [Abstract][Full Text] [Related]
15. Identification of resibufogenin, a component of toad venom, as a novel senolytic compound in vitro and for potential skin rejuvenation in male mice.
Takaya K; Asou T; Kishi K
Biogerontology; 2023 Dec; 24(6):889-900. PubMed ID: 37395866
[TBL] [Abstract][Full Text] [Related]
16. [Induction of robust senescence-associated secretory phenotype in mouse NIH-3T3 cells by mitomycin C].
Huang WX; Guo XX; Peng ZZ; Weng CL; Huang CY; Shi BY; Yang J; Liao XX; Li XY; Zheng HL; Liu XG; Sun XR
Sheng Li Xue Bao; 2017 Feb; 69(1):33-40. PubMed ID: 28217805
[TBL] [Abstract][Full Text] [Related]
17.
Woo J; Shin S; Ji H; Ryu D; Cho E; Kim Y; Kim J; Park D; Jung E
Nutrients; 2022 May; 14(9):. PubMed ID: 35565945
[TBL] [Abstract][Full Text] [Related]
18. Senescent cells and SASP in cancer microenvironment: New approaches in cancer therapy.
Özdemir A; Şimay Demir YD; Yeşilyurt ZE; Ark M
Adv Protein Chem Struct Biol; 2023; 133():115-158. PubMed ID: 36707199
[TBL] [Abstract][Full Text] [Related]
19. Orally-active, clinically-translatable senolytics restore α-Klotho in mice and humans.
Zhu Y; Prata LGPL; Gerdes EOW; Netto JME; Pirtskhalava T; Giorgadze N; Tripathi U; Inman CL; Johnson KO; Xue A; Palmer AK; Chen T; Schaefer K; Justice JN; Nambiar AM; Musi N; Kritchevsky SB; Chen J; Khosla S; Jurk D; Schafer MJ; Tchkonia T; Kirkland JL
EBioMedicine; 2022 Mar; 77():103912. PubMed ID: 35292270
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of senescent cell secretomes to identify common and specific features of the different senescent phenotypes: a tool for developing new senotherapeutics.
Oguma Y; Alessio N; Aprile D; Dezawa M; Peluso G; Di Bernardo G; Galderisi U
Cell Commun Signal; 2023 Sep; 21(1):262. PubMed ID: 37770897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]